Search - tctmd.com

Displaying 801 - 820 of 1287

Sort: Relevancy | Date

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

News Daily News

NCDR Data Show Relationship Between Volume, Outcomes in Primary PCI for STEMI

L.A. McKeown

December 05, 2013

News Daily News

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

December 02, 2013

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News AHA 2013

Risk of Kidney Injury Not Affected by High-Potency Statin Regimen in ACS Patients

Yael L. Maxwell

November 20, 2013

News Conference News AHA 2013

Endovascular Revascularization Benefits PAD Patients When Added to Exercise Therapy

Yael L. Maxwell

November 18, 2013

News Daily News

SCAI Paper Outlines ‘Best Practices’ for FFR, IVUS, OCT

Yael L. Maxwell

November 14, 2013

News Conference News TCT 2013

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

November 06, 2013

Presentation TCT 2013

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

Presenter: Dean Kereiakes

October 31, 2013

Presentation TCT 2013

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

Presenter: Mathew Williams

October 31, 2013

News Industry News

New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy

October 31, 2013

News Industry News

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

October 31, 2013

Presentation TCT 2013

Guidelines for Commercial TAVR Site Selection in the United States

Presenter: Rhonda Robb

October 31, 2013

Presentation TCT 2013

Welcome and Introduction: The Purpose of the FDA Town Hall Meeting

Presenter: Martin Leon

October 30, 2013

News Conference News TCT 2013

TCT Takes Paperless to a New Level

October 30, 2013

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

News Industry News

Study Demonstrates High Accuracy of Non-Invasive Computed FFR in Evaluating

October 30, 2013

Presentation TCT 2013

Status Update on European Medical Device Regulatory Reform Initiatives

Presenter: Alan Fraser

October 30, 2013

News Conference News TCT 2013

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

October 30, 2013

News Conference News TCT 2013

Regulatory Hurdles Pose Challenges for Device Approvals in US, Europe

October 30, 2013

Advertisement

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

NCDR Data Show Relationship Between Volume, Outcomes in Primary PCI for STEMI

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

Risk of Kidney Injury Not Affected by High-Potency Statin Regimen in ACS Patients

Endovascular Revascularization Benefits PAD Patients When Added to Exercise Therapy

SCAI Paper Outlines ‘Best Practices’ for FFR, IVUS, OCT

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

Guidelines for Commercial TAVR Site Selection in the United States

Welcome and Introduction: The Purpose of the FDA Town Hall Meeting

TCT Takes Paperless to a New Level

TCT Leadership Outlines the State of Intervention

Study Demonstrates High Accuracy of Non-Invasive Computed FFR in Evaluating

Status Update on European Medical Device Regulatory Reform Initiatives

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

Regulatory Hurdles Pose Challenges for Device Approvals in US, Europe

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content